Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2023 - 2025)
Historic Return on Invested Capital for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to 2.55%.
- Rhythm Pharmaceuticals' Return on Invested Capital rose 79800.0% to 2.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.55%, marking a year-over-year increase of 79800.0%. This contributed to the annual value of 2.75% for FY2024, which is 19000.0% down from last year.
- Rhythm Pharmaceuticals' Return on Invested Capital amounted to 2.55% in Q3 2025, which was up 79800.0% from 28.6% recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Return on Invested Capital registered a high of 0.76% during Q1 2022, and its lowest value of 28.6% during Q2 2025.
- Its 4-year average for Return on Invested Capital is 7.53%, with a median of 3.92% in 2024.
- The largest annual percentage gain for Rhythm Pharmaceuticals' Return on Invested Capital in the last 5 years was 79800bps (2025), contrasted with its biggest fall of -233100bps (2025).
- Quarter analysis of 4 years shows Rhythm Pharmaceuticals' Return on Invested Capital stood at 0.76% in 2022, then dropped by -27bps to 0.96% in 2023, then tumbled by -1510bps to 15.42% in 2024, then skyrocketed by 83bps to 2.55% in 2025.
- Its last three reported values are 2.55% in Q3 2025, 28.6% for Q2 2025, and 7.89% during Q1 2025.